Please assess the completion status of the following clinical trial:

Trial Title: Omega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infants born less than or equal to 30 weeks gestation or less than 1500 g at birth~Exclusion Criteria:~* Patients with liver disease as tested by liver function tests (LFTs)~* ≤ 500 grams birthweight

- Gender: ALL
- Minimum Age: None
- Maximum Age: 7 Days
- Healthy Volunteers: f

Study Arms:
- Standard of Care (Standard Nutrition) (Type: ACTIVE_COMPARATOR): Infants in this group will receive standard lipids (predominantly Omega-6 fatty acids).
- Omegaven (Type: EXPERIMENTAL): Infants in this group will receive lipid supplementation with omega-3 fatty acids.

Based on this trial design, predict the completion outcome and termination type (if applicable).